Silicon Laboratories Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Silicon Laboratories wird ein jährliches Gewinn- und Umsatzwachstum von 147.5% bzw. 14.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 147.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.1% betragen.
Wichtige Informationen
147.5%
Wachstumsrate der Gewinne
147.52%
EPS-Wachstumsrate
| Semiconductor Gewinnwachstum | 25.8% |
| Wachstumsrate der Einnahmen | 14.5% |
| Zukünftige Eigenkapitalrendite | 12.10% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 06 May 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Analyse-Update • May 06
SLAB: Higher Margin Assumptions And P E Frameworks Will Shape Future Returns
Analysts have raised their average price targets on Silicon Laboratories by double digit dollar amounts, pointing to updated assumptions around discount rates, profit margins and future P/E multiples as key drivers of the new $222.86 estimate. Analyst Commentary Across the latest research updates, bullish analysts are resetting their models on Silicon Laboratories around higher price targets, with several revisions in the $45 to $101 range that feed into the new average target of $222.86.Analyse-Update • Apr 20
SLAB: Merger Terms And Hold Ratings Will Guide Deal Driven Returns
Silicon Laboratories' updated analyst price targets have shifted higher by a double digit dollar amount, with many analysts pointing to refreshed views on valuation assumptions, even as recent research includes a mix of upward target revisions and downgrades to Hold. Analyst Commentary Recent Street research on Silicon Laboratories has been active, with several firms adjusting price targets and others moving to Hold ratings.Analyse-Update • Apr 04
SLAB: Merger Terms And Mixed Ratings Will Shape Deal Driven Return Profile
Silicon Laboratories' analyst price targets have shifted higher by double-digit dollar amounts, reaching up to $101, as analysts recalibrate their views using updated assumptions for profit margins, discount rates, and future P/E multiples. Analyst Commentary Recent Street research on Silicon Laboratories shows a wide range of views, with some analysts lifting price targets by double digit dollar amounts and others moving to more neutral stances.Analyse-Update • Mar 20
SLAB: Deal Terms And Mixed Ratings Will Shape Merger Driven Return Profile
Silicon Laboratories' updated analyst price target has shifted in line with modest tweaks to the discount rate, profit margin and future P/E assumptions, as analysts weigh a mix of recent target hikes from $45 to $101 alongside several fresh downgrades to Hold. Analyst Commentary Street research on Silicon Laboratories has recently clustered around two camps, with some raising price targets by sizeable dollar amounts and others shifting to Hold.Analyse-Update • Mar 05
SLAB: Deal Terms And Mixed Ratings Will Guide Future Return Profile
Silicon Laboratories' analyst price targets have moved higher by a wide range, with several firms lifting their views by $45 to $101 as analysts reassessed the company using slightly adjusted discount rate, profit margin and P/E assumptions. Analyst Commentary Recent research on Silicon Laboratories presents a mixed picture, with some firms lifting price targets by wide margins and others moving to the sidelines.Analyse-Update • Feb 19
SLAB: Deal Terms And Mixed Ratings Will Shape Future Upside Potential
Analysts have lifted their Silicon Laboratories fair value estimate from $164.13 to about $222.86, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that better reflect recent Street research on the name. Analyst Commentary Recent Street research on Silicon Laboratories is mixed, with several firms lifting price targets while others move to more neutral stances.Seeking Alpha • Feb 05
Silicon Labs Acquisition Is A Quiet Win For Texas Instruments
Summary Silicon Labs (SLAB) is being acquired by Texas Instruments (TXN) for $231/share in an all-cash deal, a 50% premium. The $7.5B acquisition price represents 9.55x trailing revenue and 78x trailing operating free cash flow, a strong outcome for SLAB shareholders. TXN expects $450M in annual synergies within three years, transforming SLAB from loss-making to meaningfully profitable under its umbrella. Both SLAB and TXN are rated hold; the deal is positive but current arbitrage and entry points are not compelling. Read the full article on Seeking AlphaAnalyse-Update • Feb 05
SLAB: Downgrades And Deal Uncertainty Will Cap Upside Potential
The updated analyst price target for Silicon Laboratories moves from US$150.44 to US$164.13, with analysts pointing to revised profit margin assumptions and a lower projected future P/E multiple, even as several firms have shifted to more neutral or Hold ratings following recent deal commentary. Analyst Commentary Recent research updates cluster around a more cautious stance, with several firms shifting to Hold or neutral views following deal related headlines.
Neue Analyse • Feb 05
Smart Meter And Industrial IoT Tailwinds Will Fail To Support Current Expectations
Catalysts About Silicon Laboratories Silicon Laboratories develops mixed signal wireless chips and software for Internet of Things applications across industrial, commercial, smart home and medical end markets. What are the underlying business or industry changes driving this perspective?Analyseartikel • Jul 03
Revenues Not Telling The Story For Silicon Laboratories Inc. (NASDAQ:SLAB) After Shares Rise 25%
Silicon Laboratories Inc. ( NASDAQ:SLAB ) shares have continued their recent momentum with a 25% gain in the last month...Neue Analyse • May 26
Smart Home Demand And IoT Trends Will Unlock Value
Accelerated adoption of diverse IoT applications and next-generation products is driving higher customer demand and expanded growth opportunities across new and existing segments.Analyseartikel • May 19
Optimistic Investors Push Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Up 45% But Growth Is Lacking
Silicon Laboratories Inc. ( NASDAQ:SLAB ) shareholders are no doubt pleased to see that the share price has bounced 45...Seeking Alpha • Feb 09
Silicon Laboratories: Rating Upgrade As Q4 2024 Results Are More Bullish On Outlook
Summary Upgraded Silicon Laboratories stock to strong buy due to robust 4Q24 results, confirming a bullish growth outlook, with 91% y/y revenue growth and strong segment performance. Management's 1Q25 guidance indicates accelerating growth, with 7% sequential and 67% y/y revenue growth, surpassing seasonal trends and suggesting a strong year ahead. SLAB's CGM and ESL businesses are ramping up faster than expected, validating product effectiveness and presenting significant multi-year growth opportunities. Valuation remains attractive at ~6x forward sales, with potential for re-rating towards previous highs, offering substantial upside for long-term investors. Read the full article on Seeking AlphaSeeking Alpha • Jan 21
Silicon Laboratories: The Timing To Growth Inflection Is Within Sight
Summary I recommend a buy rating for Silicon Laboratories stock due to expected strong y/y revenue growth starting in FY25, driven by AI advancements and data center investments. SLAB's efficient wireless SoCs and AI integration position it to benefit from the growing AI market. Despite recent sequential revenue growth, the market hasn't fully priced in SLAB's potential. Risks include uncertain demand recovery in industrial markets and potential impacts from rising interest rates and geopolitical tensions. Read the full article on Seeking AlphaSeeking Alpha • Nov 05
A Slower, More Stretched-Out Recovery Has Weighed On Silicon Labs
Summary Silicon Labs has underperformed the S&P 500 but fared better than many semiconductor peers, despite weak demand in major end-markets. Q3’24 results were in line with expectations, showing a double-digit year-over-year revenue decline but sequential improvement. Long-term growth opportunities in IoT markets like smart home, retail, smart metering, and glucose monitoring remain meaningful, despite current demand challenges and though guidance for Q4’24 remains soft. I've reduced my near-term fair value estimate to $115 on a slower recovery trajectory, but the potential for $130+ remains when revenue and margins recover. Read the full article on Seeking AlphaSeeking Alpha • Oct 17
Silicon Laboratories: A Questionable Outlook Offsets Improving Results
Summary Silicon Laboratories has recouped some of the losses for the year, with the stock moving higher, but there are a few reasons why further stock gains may have to wait. The excess inventory problem is getting better with the quarterly numbers rebounding, but the outlook beyond is nonetheless hazy. A continued rally in the stock requires strong growth, but it is unclear what demand and thus growth will be like without excess inventory. SLAB can move past present hurdles, but it will need to provide some answers to pressing questions, which it has not done yet. Read the full article on Seeking AlphaSeeking Alpha • Jul 31
Silicon Laboratories: Equity Story Remains Very Attractive
Summary SLAB recommended as a buy with visible recovery growth and margin expansion potential. Positive earnings report with strong sequential revenue growth and margin expansion. Growth catalyst that could potentially drive higher growth is the AI/ML opportunities. Read the full article on Seeking AlphaSeeking Alpha • Jul 14
Silicon Labs Ready For The Next IoT-Fueled Run
Summary After a 70% peak-to-trough revenue decline, Silicon Labs is stabilizing, with promising prospects in Bluetooth and WiFi markets and AI edge deployments ready to drive the next up-cycle. Following sequential growth in Q1'24, SLAB should deliver 30%-plus sequential growth in Q2'24, driven by consumer/home market restocking and new wins, including glucose monitoring. Silicon Labs’ new Series 3 chips, with significantly greater compute capacity over Series 2, position the company well for industrial AI edge installations, enhancing its competitiveness in the IoT sector. With expanding addressable market opportunities, share gains, and new product launches, SLAB could achieve mid-teens revenue growth and mid-to-high teens operating margins in three years, driving a fair value of $130-$150. Read the full article on Seeking AlphaSeeking Alpha • May 05
Silicon Laboratories: An Uncertain Recovery Outlook Continues To Linger
Summary Silicon Laboratories released a mixed report on the 24th by surpassing quarterly estimates and falling short on guidance, resulting in a drop in the stock. SLAB is making progress regarding the inventory problem, but SLAB acknowledges the problem has yet to be resolved. The latest Investor Presentation laid out ambitious targets, which paint a rosy picture for the future, but which may be overly aggressive. SLAB is recovering, but it is too early to say SLAB is out of the woods, especially given the recent weakness in the stock. Read the full article on Seeking AlphaGewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2028 | 1,218 | N/A | N/A | N/A | 1 |
| 12/31/2027 | 1,075 | 28 | 123 | 129 | 7 |
| 12/31/2026 | 925 | -13 | 64 | 99 | 6 |
| 4/4/2026 | 821 | -50 | 18 | 53 | N/A |
| 1/3/2026 | 785 | -65 | 66 | 96 | N/A |
| 10/4/2025 | 743 | -86 | 74 | 97 | N/A |
| 7/5/2025 | 703 | -105 | 75 | 95 | N/A |
| 4/5/2025 | 656 | -165 | 91 | 106 | N/A |
| 12/28/2024 | 584 | -191 | -26 | -14 | N/A |
| 9/28/2024 | 505 | -237 | -17 | -6 | N/A |
| 6/29/2024 | 542 | -198 | -85 | -71 | N/A |
| 3/30/2024 | 642 | -105 | -106 | -89 | N/A |
| 12/30/2023 | 782 | -35 | -53 | -30 | N/A |
| 9/30/2023 | 953 | 61 | -60 | -35 | N/A |
| 7/1/2023 | 1,019 | 71 | -16 | 12 | N/A |
| 4/1/2023 | 1,037 | 82 | -46 | -17 | N/A |
| 12/31/2022 | 1,024 | 91 | 45 | 72 | N/A |
| 10/1/2022 | 975 | 72 | -190 | -160 | N/A |
| 7/2/2022 | 890 | 31 | -164 | -134 | N/A |
| 4/2/2022 | 797 | -10 | -67 | -40 | N/A |
| 1/1/2022 | 721 | -58 | -129 | -100 | N/A |
| 10/2/2021 | 658 | -85 | 103 | 127 | N/A |
| 7/3/2021 | 606 | -92 | 94 | 114 | N/A |
| 4/3/2021 | 551 | -109 | 71 | 91 | N/A |
| 1/2/2021 | 511 | -115 | 118 | 136 | N/A |
| 10/3/2020 | 585 | -84 | 142 | 159 | N/A |
| 7/4/2020 | 675 | -38 | 180 | 196 | N/A |
| 4/4/2020 | 767 | -18 | 178 | 194 | N/A |
| 12/28/2019 | 474 | -103 | N/A | 167 | N/A |
| 9/28/2019 | 834 | 25 | N/A | 163 | N/A |
| 6/29/2019 | 841 | 32 | N/A | 194 | N/A |
| 3/30/2019 | 851 | 63 | N/A | 183 | N/A |
| 12/29/2018 | 868 | 84 | N/A | 174 | N/A |
| 9/29/2018 | 854 | 64 | N/A | 193 | N/A |
| 6/30/2018 | 822 | 56 | N/A | 160 | N/A |
| 3/31/2018 | 795 | 58 | N/A | 170 | N/A |
| 12/30/2017 | 769 | 47 | N/A | 190 | N/A |
| 9/30/2017 | 750 | 72 | N/A | 164 | N/A |
| 7/1/2017 | 730 | 72 | N/A | 149 | N/A |
| 4/1/2017 | 715 | 71 | N/A | 129 | N/A |
| 12/31/2016 | 698 | 61 | N/A | 129 | N/A |
| 10/1/2016 | 675 | 47 | N/A | 125 | N/A |
| 7/2/2016 | 653 | 37 | N/A | 129 | N/A |
| 4/2/2016 | 643 | 29 | N/A | 124 | N/A |
| 1/2/2016 | 645 | 30 | N/A | 105 | N/A |
| 10/3/2015 | 647 | 34 | N/A | 117 | N/A |
| 7/4/2015 | 649 | 30 | N/A | 111 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: SLAB wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.
Ertrag vs. Markt: SLAB wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.
Hohe Wachstumserträge: SLAB wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.
Einnahmen vs. Markt: SLABDie Einnahmen des Unternehmens (14.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (11.5% pro Jahr).
Hohe Wachstumseinnahmen: SLABDie Einnahmen des Unternehmens (14.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: SLABDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.1%).
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/07 06:57 |
| Aktienkurs zum Tagesende | 2026/05/07 00:00 |
| Gewinne | 2026/04/04 |
| Jährliche Einnahmen | 2026/01/03 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Silicon Laboratories Inc. wird von 28 Analysten beobachtet. 7 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Thomas O'Malley | Barclays |
| Christopher Muse | Barclays |
| Gary Mobley | Benchmark Company |